The global metabolic testing market size is valued at USD 409.96 million in 2021 and estimated to grow at a CAGR of 7.5%, to value USD 588.55 million by 2026.
Metabolism is a chemical reaction and physical process that involves maintaining the living state, such as breathing, blood circulation, contraction of muscles, digestion of food and nutrients, elimination of wastes such as urine, controlling body temperature, and functioning of brain and nerves of the organism. It is a pathway that begins with a sequence of chemical reactions with a specific molecule and ends with a product with the help of a specific enzyme. Enzymes are vital to metabolism as they allow the organism to drive reactions for the required energy. It is divided into two categories, i.e., catabolism and anabolism. A comprehensive metabolic panel is a blood test that measures your sugar (glucose) level, electrolyte and fluid balance, kidney function, and liver function.
MARKET DRIVERS:
Growing healthcare spending, the prevalence of lifestyle diseases such as diabetes and obesity, increased healthcare literacy, and technical advances are expected to promote the global metabolic testing market growth.
If the prevalence of lifestyle diseases rises, so does the need for metabolic testing, which is supposed to propel the global metabolic testing industry forward. Technological advances in the healthcare IT industry have effectively integrated diverse healthcare and IT programs. Cloud computing, data mining, big data, and patient monitoring are common in the healthcare industry. Beyond situational requirements, metabolic testing is still not a prerequisite, and metabolic testing is yet to achieve its full potential. In such a situation, linked and portable metabolic testing devices can significantly improve metabolic testing accessibility.
In the global metabolic testing market, increasing market consolidation and new product releases are among the major opportunities for the market. Introducing digital rate testing equipment, more care for individual health, and rapidly increasing healthcare expenditure levels are also expected to increase market growth during the forecast period.
MARKET RESTRAINTS:
The high cost of equipment and software and reimbursement issues are some of the major restraints to the global metabolic testing market.
Impact of COVID-19 on the global metabolic testing market:
With the Covid-19 virus rising globally, there is a shortage of essential life-saving devices and other essential medical supplies to prevent the spread of this pandemic and supply optimum care to the infected people. The Corona Virus Outbreak is significant and has far-reaching effects on the market. Many industries face critical concerns such as supply chain disruption, increasing the risk of recession, and reduction in consumer spending. Metabolism is term as a reaction and physical process to take care of the quality state of the organism or body like breathing, digestion of food and nutrients, elimination of wastes such as urine, controlling body temperature, blood circulation, contraction of muscles, and functioning of brain and nerves of the organism. The possible Comprehensive Metabolic Testing market loss expected revenue because of preference for the COVID-19 patients, who may require critical care treatment with the help of new technologies during this pandemic period.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Analysed |
By Product, Technology, Application, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
|
Companies Analysed |
Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.). |
This research report on the global metabolic testing market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2026.
Metabolic Testing Market - By Product:
Based on products, the ECG and EKG systems segment is expected to hold a leading share in the global metabolic testing market during the forecast period due to the increasing commonness of chronic illness. Rising healthcare expenditure associated with the increasing disposable income is elevating the growth of this segment.
Metabolic Testing Market - By Technology:
Based on technology, the VO2 max analysis segment attributes the largest share of the market as it is the most often prescribed metabolic procedure for athletes, caregivers, and healthier people. It directly measures the body oxygen consumption, which other tests try to estimate.
Metabolic Testing Market - By Application:
Based on the application, due to the rising prevalence of lifestyle-related diseases such as obesity, diabetes, and cardiovascular disease, the lifestyle disease segment dominates the market in terms of market share.
Metabolic Testing Market - By End User:
The resting metabolic rate determines the number of calories burned by the body at rest. Body composition analysis is a physical examination that determines the proportions of different components in the body that are primarily used to test/examine metabolic conditions, lifestyle ailments, and dysmetabolic disorders in hospitals, clinics, sports fitness centers, and gyms.
Metabolic Testing Market - By Region:
Geographically, the North American region is estimated to constitute the largest share in the global metabolic testing market. The growth of the North American market is primarily driven by the rise in the prevalence of lifestyle diseases such as cardiovascular diseases, obesity, and type 2 diabetes in this region.
In contrast, the Asia Pacific region is expected to witness the fastest growth and beat North America. Asia's growth is because of increasing healthcare spending, growing demand for quality medical care, the rising standard of living, favorable government initiatives, and growing patient awareness levels. Asia's growth is because of a rising standard of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, growing demand for medical care, etc. The rise in the adoption of advanced technologies in the metabolic testing market and well-established healthcare facilities is the regional market's growth to some extent.
KEY MARKET PARTICIPANTS:
Some of the notable companies operating in the global metabolic testing market profiled in the report are Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.) and Microlife Medical Home Solutions, Inc. (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 CPET Systems
5.1.3 Metabolic Carts
5.1.4 ECG and EKG Systems
5.1.5 Body Composition Analyzers
5.1.6 Software
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 VO2 Max Analysis
5.2.3 RMR Analysis
5.2.4 Body Composition Analysis
5.2.5 Y-o-Y Growth Analysis, By Technology
5.2.6 Market Attractiveness Analysis, By Technology
5.2.7 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Lifestyle Diseases
5.3.3 Critical Care
5.3.4 Human Performance Testing
5.3.5 Dysmetabolic Syndrome X
5.3.6 Metabolic Disorders
5.3.7 Other Applications
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Laboratories
5.4.4 Sports Training Centers
5.4.5 GYMS
5.4.6 Other End Users
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.1.5.5 By End User
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Parvo Medics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Microlife Medical Home Solutions, Inc.
8.3 Korr Medical Technologies, Inc.
8.4 Cosmed
8.5 Cortex Biophysik GMBH
8.6 AEI Technologies, Inc.
8.7 OSI Systems, Inc.
8.8 MGC Diagnostics Corporation
8.9 Geratherm Medical AG
8.10 General Electric Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
